---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-006534"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:19:12.087315+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Annovis Bio closes common stock purchase agreement with equity line investor

## Summary
- Closed transactions contemplated by Common Stock Purchase Agreement entered April 25, 2024.
- Equity line investor purchased shares; no specific dollar amount or share count disclosed.
- Loeb & Loeb LLP opinion on securities issuance filed as Exhibit 5.1.

## SEC filing metadata
- accession: 0001558370-24-006534
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000155837024006534/0001558370-24-006534-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000155837024006534/anvs-20240502x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-006534
- JSON: https://secwatch.observer/filing/0001558370-24-006534.json
- Plain text: https://secwatch.observer/filing/0001558370-24-006534.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.